COMPARISON OF TOXICITY OF MITOZANTRONE AND DOXORUBICIN WHEN USED IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE FOR ADVANCED BREAST-CANCER

被引：0
作者：
HALL, VL [1 ]
BUCHANAN, RB [1 ]
WILLIAMS, CJ [1 ]
机构：
[1] ROYAL S HANTS HOSP,COMBINED BREAST CLIN,SOUTHAMPTON SO9 4PE,HANTS,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1988年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：263 / 263
页数：1
相关论文
共 50 条
  • [31] TAMOXIFEN (T) IN COMBINATION WITH FLUOROURACIL, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (FAC) FOR TREATMENT OF ADVANCED BREAST-CANCER
    SMITH, L
    BUZDAR, A
    LEGHA, S
    HORTOBAGYI, G
    BLUMENSCHEIN, G
    BREAST CANCER RESEARCH AND TREATMENT, 1984, 4 (04) : 350 - 350
  • [32] MITOXANTRONE COMBINED TO VINCRISTINE, CYCLOPHOSPHAMIDE AND FLUOROURACIL IN ADVANCED BREAST-CANCER
    METZ, R
    DELGADO, M
    KEILING, R
    CAPPELAERE, P
    ARMAND, JP
    PREVOT, G
    MISSET, JL
    GRIMBERT, J
    MATHE, G
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) : 163 - 166
  • [33] DOES VINCRISTINE CONTRIBUTE TO ADRIAMYCIN IN THE TREATMENT OF ADVANCED BREAST-CANCER
    MINTON, MJ
    SEXTON, SA
    CANTWELL, BMJ
    SPARROW, GEA
    KNIGHT, RK
    RUBENS, RD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 408 - 408
  • [34] DOSE-INTENSE WEEKLY CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, VINCRISTINE AND PREDNISOLONE (CMVFP) IN ADVANCED BREAST-CANCER
    CEBON, JS
    BISHOP, JF
    HARVEY, V
    MASON, B
    JEAL, PN
    BRITISH JOURNAL OF CANCER, 1990, 61 (01) : 133 - 136
  • [35] ADRIAMYCIN ALONE OR COMBINED WITH VINCRISTINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    STEINER, R
    STEWART, JF
    CANTWELL, BMJ
    MINTON, MJ
    KNIGHT, RK
    RUBENS, RD
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (11): : 1553 - 1557
  • [36] CONTRIBUTION OF PREDNISOLONE TO THE PRIMARY ENDOCRINE TREATMENT OF ADVANCED BREAST-CANCER
    STEWART, JF
    RUBENS, RD
    KING, RJB
    MINTON, MJ
    STEINER, R
    TONG, D
    WINTER, PJ
    KNIGHT, RK
    HAYWARD, JL
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12): : 1307 - 1314
  • [37] DOXORUBICIN AND ETOPOSIDE IN THE TREATMENT OF ADVANCED MEASURABLE BREAST-CANCER
    GIACCONE, G
    DONADIO, M
    BONARDI, G
    TESTORE, F
    CALCIATI, A
    ONCOLOGY, 1990, 47 (02) : 105 - 108
  • [38] COMBINATION CHEMOTHERAPY WITH PREDNIMUSTINE, ADRIAMYCIN, VINCRISTINE (VAP) IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    KOSMIDIS, PA
    FOUNTZILAS, G
    ATHANASSIOU, A
    KARABELIS, A
    MYLONAKIS, N
    TSAVARIS, N
    KARVOUNIS, N
    BACOJIANNIS, C
    CHEMIOTERAPIA, 1987, 6 (06): : 393 - 395
  • [39] PHASE-II STUDY OF COMBINATION VINCRISTINE, EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER IN CHINESE PATIENTS
    SHIU, W
    TAO, M
    LEUNG, T
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) : 1710 - 1710
  • [40] TOXICITY OF INTRA-ARTERIAL DOXORUBICIN (DOX) IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER (LABC)
    TWELVES, CJ
    CHAUDARY, M
    REIDY, J
    RUBENS, RD
    RICHARDS, MA
    BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 456 - 457
12345